• NEW
    Blog
    Aug. 03, 2026

    In Part 1 of this series, Why the Migration Clock Has Already Started, we explained why Banking, Financial Services and Insurance (BFSI) enterprises cannot wait for a formal mandate to begin their Post-quantum Cryptography (PQC) migration and estimated a roughly US$7 billion spending opportunity across the top…
  • Blog
    July 21, 2026

    Current state of cryptography in BFSI  Banks, insurers, and capital markets enterprises have been using cryptography for a long time across every important part of their business. It protects everything from mobile payments to complex trading platforms and third-party connections.  …
  • Blog
    July 08, 2026

    Artificial Intelligence (AI) is having its moment. After years of cautious skepticism, pilot-stage overhang, and boardroom debates, the conversation has moved beyond experimentation. Enterprises are no longer asking whether to deploy agents, they are now asking how fast they can scale them across their entire workflow estate. However, speed comes at a price and almost nobody is doing the math.   The warning signs…
  • Provider Compendium
    Dec. 30, 2025

    Enterprises are repositioning quality from a downstream testing activity to a strategic engineering capability embedded across the software development life cycle. As digital, cloud, and AI initiatives scale, expectations are moving beyond defect identification toward resilience,…
  • PEAK Matrix®
    Nov. 13, 2025

    Enterprises are elevating quality from a downstream test phase to a strategic engineering discipline woven through the software development life cycle. As digital, cloud, and AI programs scale, expectations shift from defect detection to resilience, velocity,…
  • Viewpoint
    Nov. 10, 2025

    As enterprises accelerate digital transformation and embrace next-generation technologies such as AI, generative AI, and cloud-native platforms, managing quality at scale has become increasingly complex. Traditional tool-centric quality approaches fall short in addressing fragmented processes, inconsistent…
  • PEAK Matrix®
    Oct. 29, 2025

    Enterprises are reimagining quality as a strategic engineering function rather than a downstream testing activity. As a result, demand for specialized Quality Engineering (QE) services is growing rapidly across industries. This analysis shows how the specialists…
  • May 12, 2025

    Introduction: The evolving landscapeArtificial Intelligence (AI) is revolutionizing industries, and Private Equity (PE) firms are rapidly adapting to harness its benefits. With record-breaking fundraising and considerable dry powder providing a strong capital base, PE firms are…
  • Video
    Aug. 20, 2024

    In this video, Everest Group’s sustainability and impact sourcing experts discuss how the expansion of access to higher education in India has become a priority with successes in rural locations. Unfortunately, the same is not the…
  • July 24, 2024

    Automation has evolved from basic tasks to advanced Intelligent Automation (IA), significantly modifying enterprise operations. As enterprises aim to scale their automation capabilities, adopting a Unified Intelligent Automation Platform (UIAP) is vital. Enterprises can use gen…
  • Blog
    May 14, 2024

    Discover the transformative power of impact sourcing firsthand through Everest Group’s sustainability teams’ eye-opening visit to a NextWealth center in rural India.Stepping out of our vehicle after a six–hour trip from our office in Bengaluru, Karnataka,…
  • Viewpoint
    April 16, 2024

    The life science industry’s focus on driving improved customer experiences has steadily grown. Investments to improve customer experiences rank among the top priorities of life sciences enterprises. These enterprises must align customer engagement strategies with the…
  • Market Insights™
    March 12, 2024

  • Market Insights™
    March 12, 2024

  • Market Insights™
    March 12, 2024

  • Provider Compendium
    March 08, 2024

    As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios,…
  • Viewpoint
    Feb. 05, 2024

    In the rapidly evolving life sciences landscape, where the pursuit of innovative therapies and life-saving drugs never ceases, science and technology are increasingly playing a vital role. High-performance Computing (HPC) stands at the forefront of this…
  • PEAK Matrix®
    Jan. 18, 2024

    As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios,…
  • Thematic Report
    Jan. 18, 2024

    Despite generative AI’s decades-long exploration into generating new content, some industry leaders express optimism, while others still navigate the uncharted waters of its potential and grapple with ethical complexities. As enterprises adopt generative AI in innovative…
  • Provider Compendium
    Dec. 21, 2023

    In response to the global shift in investment priorities toward personalized Customer Experience (CX) post-pandemic, the life sciences commercial technology space is also redirecting its focus. Adapting to the changing landscape, the industry is increasingly leveraging…

Items per page